新闻报导
Medidata Solutions 的产品引起科学界和IT界的高度关注，以下是有关公司近期部分精彩的报道。2013
The CNBC and Yahoo! Finance “Big Data Download” series features Medidata president Glen de Vries discussing how big data can help make the drug development process more efficient, cutting trial timelines and costs and ultimately creating better outcomes for patients.
阅读
Medidata CEO Tarek Sherif is included in Chief Executive magazine's list of “Eight State Advocate CEOs,” part of its “2013 Best and Worst States for Business” series, and is highlighted for his role promoting other tech-entrepreneurship in NYC by mentoring CEOs of start-ups and supporting local university programs that foster business innovators.
阅读
Speaking with TheStreet.com, Medidata CEO Tarek Sherif discusses how the Medidata Clinical Cloud is helping life science organizations bring better drugs to market, faster and with less cost and risk.
查看
Medidata president Glen de Vries is named one of the “20 Innovators Changing the Face of the Clinical Trials Industry” in the April issue of The CenterWatch Monthly for pushing the envelope of cloud-based technologies in clinical development.
阅读
The April issue of ACRP's The Monitor features Medidata senior product director Stephen Young as he discusses his career evolution from aerospace to the world of clinical development, and how his passion for analytics and data-driven development led him to this change.
阅读
A recent FierceBiotechIT article highlights the roles of Medidata Solutions and Digital Infuzion in a groundbreaking observational study by Inova Translational Medicine Institute, which will examine the correlation between a child’s genetic profile, their development and their long-term health. Together, Medidata and Digital Infuzion will deliver a web-based portal and cloud technology that will act as a repository for patient data and will enable the review of study progress and access to surveys and study information.
阅读
This FierceBiotechIT article offers insights from a recent webinar session, “Drugmakers go mobile,” moderated by executive editor Ryan McBride. Medidata Solutions president Glen de Vries presented—along with industry experts from Genentech, Dotmatics and Kony Solutions—on how pharma companies are embracing digital health and the use of mobile.
阅读
Veeva Systems' blog Veeva Voice features a post by Medidata director of product marketing Jay Smith on the challenge and potential of cloud-based electronic trial master files (eTMF) and how they can revolutionize the management of clinical trials.
阅读
In this eCliniqua article, Medidata product manager Igor Altman discusses the key issues for ensuring success when adopting new processes for study design optimization.
阅读
In a recent Software Magazine article on the evolving healthcare industry and how it opens doors for new and improved IT solutions, Medidata president Glen de Vries discusses the meaningful use of electronic health record (EHR)/electronic medical record (EMR) systems and how Medidata’s cloud-based platform helps to reduce cost, reduce risk, and enhance efficiency in all stages of the clinical trial process.
阅读
FierceBiotech highlights Purdue Pharma's recent multiyear deal with Medidata Solutions, broadening its already wide use of Medidata’s cloud-based solutions. The adoption will further enhance Purdue's clinical trials for pain medication.
阅读
In a recent PharmaVOICE article on the future of the cloud in clinical research, Medidata president Glen de Vries shares his insight on how the cloud era will go beyond convenience and speed by bringing increased productivity across the trial team.
阅读
In the January/February issue of Journal for Clinical Studies, Medidata’s vice president of trial planning solutions Frank Cattie discusses the three key variables of overall study cost—protocol complexity, geography and phase and indication—as well as ways for sponsors to control these variables, reduce study risk and increase performance predictability.
阅读
Applied Clinical Trials online in January features a Medidata Insights benchmark for source document verification (SDV) coverage. Part of a monthly series highlighting industry metrics, this edition focuses on how FDA guidance on risk-based monitoring has impacted SDV coverage across the industry.
阅读
2012
Forbes' Matthew Herper highlights the Forbes Healthcare Summit panel discussion on big data, led by Medidata president Glen de Vries. The feature includes video clips from the event in which Glen discusses how technology and the copious amount of data collected can help improve productivity in life sciences and health care as a whole.
阅读
In a recent article posted by Journal for Clinical Studies, vice president of clinical solutions Jeffrey Handen discusses the need to adopt a more responsive, adaptive and agile model for clinical trials—as well as the evolution of the tools and methodologies needed to efficiently support this model—in order to reduce the product development life-cycle in drug development.
阅读
In a Fast Company feature profiling managers who are navigating big job transitions, Medidata’s human resources project manager Naimisha Chanumolu discusses the challenges of going from a software engineer working alone to a project manager overseeing a team of 25.
阅读
In a recent PharmaVOICE article on how the optimization of certain processes in clinical development is vital for the timely and efficient approval of new treatments, director of product management Michelle Marlborough assesses the impact of unnecessary procedures in a protocol, referencing the recent Medidata-sponsored study by the Tufts Center for the Study of Drug Development.
阅读
In the November/December issue of PharmaVOICE, President Glen de Vries—along with other thought leaders from all sectors of the industry—offers his viewpoint on the most important business objectives for life sciences, both into the new year and beyond.
阅读
In the November/December issue of PharmaVOICE, vice president of trial planning solutions Frank Cattie discusses the importance of considering protocol site work effort (SWE) in determining payment levels in order to avoid extended site negotiations, delayed start-ups and low site satisfaction.
阅读
Applied Clinical Trials online in November features Medidata Insights™ benchmarks for data entry times and data correction rates. Part of a monthly series highlighting industry metrics, this edition focuses on the impact of delays in entering data on the relative quality of the data being entered.
阅读
In InformationWeek’s 2012 State of IT Staffing Survey—which examines the evolving role of application delivery specialists and career prospects for people with these skills—senior vice president of applications and platform Vikram Shah comments on how the cloud has changed how clinical trial software is developed, deployed and delivered.
阅读
In this issue of Journal for Clinical Studies, director of CRO partnerships Julian de Bres shares his vision on how clinical research organizations (CROs) and their growing relationships with sponsors drive drug development and leverage clinical trial technology to optimize their studies.
阅读
In the fall issue of SCDM Data Basics, vice president of implementation services Marco van Doeveren discusses the power and breadth of cloud computing to better manage the increasing volume and complexity of clinical data.
阅读
FierceBiotechIT highlights 15 mobile apps in life sciences for 2012, including Medidata Patient Cloud™, a new app built to simplify patient data collection on iOS® devices such as the iPhone® and iPad®.
阅读
Applied Clinical Trials online in October features a Medidata Insights™ benchmark for EDC autoquery rates. Part of a monthly series highlighting industry metrics, this edition focuses on the relationship between EDC autoquery rates and site quality.
阅读
In a recent Scrip Clinical Research article, director of product management Michelle Marlborough and senior manager of product marketing Joshua Pines discuss the increase in clinical trial complexity, concentrating on non-core procedures in protocol development and what organizations can do to minimize them.
阅读
FierceBiotech’s Ryan McBride features Medidata as a key player driving the advancement of clinical trials in Japan as vaccine maker KAKETSUKEN becomes the first Japanese pharma company to implement Medidata’s cloud-based solutions for randomization, trial supply management, electronic data capture and clinical data management.
阅读
In the September issue of Journal for Clinical Studies, senior manager of product marketing Sean Cheng analyzes current trends in source document verification (SDV), highlighting obstacles to overcome and pointing to the need for further awareness and adoption of risk-based practices.
阅读
A recent eCliniqua article highlights how Medidata’s deployment of Opscode Hosted Chef enables automated IT infrastructure in the cloud across clinical development processes, delivering new solutions securely in real-time.
阅读
Bio-IT World’s eCliniqua reports on the launch of new research from U.S. Department of Health and Human Services (HHS), which uses Medidata’s comprehensive trial cost database products to identify factors that delay or derail clinical studies and help assess policies that encourage and enable more streamlined and efficient trials.
阅读
Medidata’s vice president of information security and privacy Glenn Watt is featured in a recent Crain’s New York Business article on the popularity of hackathons as cost-effective tools to identify problems, attract talent and unleash innovation at NYC businesses. Glenn provides insight into how Medidata leverages hackathons to hack into their own code and expose bugs, helping to improve the security of its solutions for customers.
阅读
Applied Clinical Trials online in September features a Medidata Insights™ benchmark for query rates. Part of a monthly series highlighting industry metrics, this edition focuses on the rate at which clinical data is queried—whether by data managers, clinical (site) monitors, medical monitors or EDC systems (autoqueries)—which can be used to estimate the quality of clinical sites.
阅读
In a Fast Company article on key steps to building a successful business, Medidata President Glen de Vries shares about Medidata's history and growth path to becoming the forward-thinking technology company it is today.
阅读
Medidata's vice president of implementation services Marco van Doeveren has been named one of the most influential people in clinical technology in the PharmaVOICE 100. Marco is awarded for his efforts behind Medidata's success helping mid-market organizations to reap the full benefits of advanced technology in clinical trials.
阅读
In an article summarizing themes from recent tech company earnings announcements, The Street names cloud, storage and security as hot technology areas, referring to Medidata Solutions and CEO Tarek Sherif.
阅读
Applied Clinical Trials online in August features a Medidata Insights™ benchmark for protocol complexity. Part of a monthly series highlighting industry metrics, this edition focuses on the increasing complexity seen in clinical trials protocols in the past decade, and how despite continued warnings from experts on the topic, complexity continues on an upward, though admittedly less steep, trend.
阅读
In the summer issue of International Clinical Trials, director of EMEA regional sales Richard Young discusses how technology is modernizing data management best practices, helping clinical researchers to better ensure trial integrity, lower trial costs, and make a risk-based monitoring approach a reality.
阅读
FierceBiotech reports on the rapid growth of the eClinical market in China and other low-cost regions due to increased outsourcing and adoption of eClinical platforms like Medidata’s cloud-based solutions.
阅读
In a Fortune article on the impact of health care legislation on technology, executive vice president of strategy and corporate development Bryan Spielman shares how results from a recent Medidata-sponsored study—which unveiled that 25% of all clinical trial procedures are potentially unnecessary—open opportunities to increase data efficiency.
阅读
Outsourcing-Pharma.com spotlights Medidata’s CEO on effective M&A strategies for the clinical technology market, including targeting organizations with similar corporate cultures and complementary, rather than overlapping, capabilities.
阅读
In a July Outsourcing-Pharma.com article, CEO Tarek Sherif comments on the future success of the eClinical space, and how its rapid growth and change is positioning Medidata to become "the leading provider of the clinical cloud."
阅读
Pharmalot reports on the recent Medidata-sponsored study conducted at the Tufts Center for the Study of Drug Development, outlining key findings on unnecessary clinical trial procedures and ways to improve protocol feasibility.
阅读
In a July article posted on PharmaPhorum.com, senior product marketing manager Joshua Pines and senior product director Stephen Young explain how adopting site quality management can streamline monitoring and improve data quality.
阅读
In the summer issue of European Biopharmaceutical Review, manager of product management Sonia Araujo discusses how Europe is rewriting the rules and processes of pharmacovigilance in a move to make regulation more risk-based and proportionate, ultimately empowering patients and saving lives.
阅读
The Medidata-sponsored Tufts study made eCliniqua's list of top news and product releases from DIA 2012, which took place June 24–28. President Glen de Vries says the study "emphasizes the increasing role technology, and the expertise around it, will continue to play in helping drug developers design, conduct and manage efficient and effective clinical trials."
阅读
FierceCRO features the Medidata-sponsored study conducted by researchers from the Center for the Study of Drug Development at the Tufts University School of Medicine. The study examines data from 115 clinical trials and more than 22,000 procedures, and reveals that eliminating non-core procedures could save the industry up to $5 billion a year.
阅读
PharmaTimes Online highlights the Medidata-sponsored Tufts study, which showcases how clinical trial sponsors spend $3–5 billion a year in unnecessary medical procedures on patients enrolled in their clinical trials.
阅读
In the July issue of The New York Enterprise Report, president Glen de Vries sets the record straight about the misconceptions of owning a business in New York City, the greatest city in the world.
阅读
On Outsourcing-Pharma.com, director of product management Michelle Marlborough discusses new Medidata sponsored study results, which reveal up to $5 billion in potential clinical trial cost savings and how better study design can help.
阅读
Applied Clinical Trials online in July features Medidata Insights™ benchmarks on the increasing intensity of on-site monitoring. The annual trends of two critical monitoring efficiency metrics, Monitoring On-Site Rate and SDV Velocity, shows that site monitors are spending increasingly more days on-site per year and performing increasing amounts of SDV during each on-site day. The post is part of a monthly series highlighting industry metrics.
阅读
In the June issue of European Pharmaceutical Contractor, vice president of partnerships and alliances Graham Bunn discusses the evolution of engagement in CRO and sponsor relationships, and how communication and technology can shape strategic partnerships in the future.
阅读
In the June issue of PharmaVOICE, president Glen de Vries shares insight on the clinical cloud and how new technologies will shape the future of clinical trials.
阅读
President Glen de Vries discusses the political landscape of healthcare, as well as the need for more effective and more valuable therapies, in the June issue of PharmaVOICE.
阅读
Applied Clinical Trials online in June features a Medidata Insights™ benchmark for eCRF design complexity. Part of a monthly series highlighting industry metrics, this edition focuses on the alarming increase in complexity seen in recent years.
阅读
As part of a series of videos commemorating the 20th anniversary of Applied Clinical Trials, Medidata's vice president of channel sales Steve Heath discusses the past and the future of the clinical trials industry.
阅读
In the May issue of Pharma Focus Asia, director of China development Daniel Liu discusses the major regulatory practices related to conducting clinical trials in China, and how the quality of clinical research has improved due to the State Food and Drug Administration’s amendment of the Chinese Good Clinical Practice (GCP) guidance.
阅读
Westat, an employee-owned research corporation, recently introduced Medidata Rave clinical data management services to support cancer Cooperative Groups as part of the Cancer Trials Support Unit (CTSU), a program of the National Cancer Institute (NCI). Westat presented at the Americas Medidata User Group (A-MUG) in May to share its Rave-related skills and approaches.
阅读
The New York Times “The Boss” column features Medidata president Glen de Vries, highlighting how ballroom dancing has impacted his approach to business and helped him lead Medidata to its market-leading position today.
阅读
Applied Clinical Trials online in May features a Medidata Insights™ benchmark for site performance. Part of a monthly series highlighting industry metrics, this edition focuses on the high percentage of clinical trial sites that fail to enroll a single patient.
阅读
The Clinical Data Interchange Standards Consortium (CDISC) announces the release of the Protocol Representation "Toolkit," a standard format for study protocol data designed to save time and resources. Medidata Solutions will be providing the underlying technology for the Protocol Representation Model (PRM) Wizard, available in the next version.
阅读
In this April eCliniqua feature, Medidata senior business consultant Jessica Dolfi examines how technological developments can streamline site negotiation processes to accelerate site budgeting and contracting.
阅读
Applied Clinical Trials online in April features a Medidata Insights™ benchmark for data correction. Part of a monthly series highlighting industry metrics, this edition focuses on the remarkably low rate of post-capture data correction during clinical trials.
阅读
Forbes spotlights Medidata Solutions for its market leadership in software for clinical trials.
阅读
In its inaugural “Top 10 Biotech Techies” list, FierceBiotech honors Medidata president Glen de Vries and profiles him as builder of the clinical trial cloud.
阅读
FierceBiotechIT reviews Arlene Weintraub’s profile on Medidata in Xconomy and a report from TheStreet, illustrating how the company is being “lauded on Wall Street.”
阅读
Glenn Watt, Medidata’s vice president of information security and privacy, shares six key steps to reducing information security costs while ensuring sufficient risk controls in Information Management.
阅读
Applied Clinical Trials online in March features Medidata Insights™ benchmarks for form design. Part of a monthly series highlighting industry metrics, this edition highlights a surprising lack of correlation between eCRF design timelines and the rate of eCRF reuse.
阅读
Xconomy New York editor and veteran healthcare and life sciences writer Arlene Weintraub highlights how “Medidata Gains Raves on Wall Street,” driven by increasing demand for its cloud-based clinical development solutions and the vision and innovation of president Glen de Vries and CEO Tarek Sherif.
阅读
In a March ComputerWorld feature examining agile development methods and outsourcing, Medidata’s senior vice president of research and development Andrew Newbigging discusses the company’s transition to agile and why developing in-house was the better strategy for meeting customer needs.
阅读
Applied Clinical Trials online features a Medidata Insights™ benchmark on geographic shifts in enrollment. This unexpected trend in global subject enrollment was posted in February as part of a monthly series highlighting industry metrics.
阅读
FierceBiotech IT highlights Medidata as “the cloud for clinical data” in this January article featuring president Glen de Vries’ Q&A in Bio-IT World.
阅读
Applied Clinical Trials online features a Medidata Insights™ benchmark on source data verification, posted in January as the first of a monthly series highlighting industry metrics.
阅读
Medidata president Glen de Vries chats with Bio-IT World’s chief editor about the history of the company and the focus on optimizing clinical trials from concept to conclusion, in this January Q&A on the state of e-clinical technologies.
阅读
2011
In the fall issue of The Security Journal, Medidata's vice president of information security and privacy, Glenn Watt, discusses how organizations can view information security strategically in software development without falling victim to high costs.
阅读
In the December issue of Journal for Clinical Studies, Medidata authors Jessica Dolfi and Sondra Pepe discuss the impact of the impending Sunshine Act on clinical trial sponsors.
阅读
In eCliniqua’s December issue, Medidata’s Michelle Marlborough, director of product management, and Joshua Pines, senior product marketing manager, encourage protocol authors to think of themselves as data archaeologists, analyzing previous research to uncover and replicate best practices.
阅读
Medidata’s vice president of partnerships and alliances, Graham Bunn, notes the qualities of effective CRO-sponsor relationships in Life Science Leader’s December issue.
阅读
Medidata director of product marketing Stan Haavik, traces the development of interactive response technology (IRT) systems used in clinical trials for randomization, supply planning and implementation, in the December issue of Applied Clinical Trials.
阅读
In the December issue of European Pharmaceutical Review, Medidata’s senior director of development Jeffrey Cohen and senior product marketing manager Joshua Pines discuss the standards created to help simplify integration between clinical technology solutions, and the external systems managing EHRs and medical images.
阅读
ComputerWorld includes Medidata in a December article highlighting 10 selected firms that are looking to hire tech workers.
阅读
Patrick Chassaigne, director, late phase solutions, explores the patients role in Phase IV studies and registries, in the November/December Year in Preview issue of PharmaVOICE. Vice president of clinical solutions Jeffrey Handen also weighs in on engaging the patient as a drug development partner and president Glen de Vries highlights three top trends impacting R&D.
阅读 (Patrick Chassaigne) | 阅读 (Jeffrey Handen) | 阅读 (Glen de Vries)
In a PharmExec guest blog post, Medidata director of late phase solutions Patrick Chassaigne discusses ways to drive patient participation in post-approval studies.
阅读
In the autumn 2011 issue of International Clinical Trials, Medidata’s vice president of data operations Lori Shields discusses the importance of new technological tools that help sponsors and sites meet their budget needs and increase study efficiency.
阅读
Medidata’s director of product management Michelle Marlborough comments on the importance of structured protocol designs to minimize costly mid-study amendments in the October 2011 issue of CenterWatch Monthly.
阅读
Medidata's acquisition of Clinical Force, featured in the September issue of PharmaVOICE, leads to new clinical trial management solutions (CTMS) offerings. The issue also highlights product announcements for Medidata Standards Accelerator, Insights and Coder.
阅读
Medidata senior vice president of development Andrew Newbigging named to PharmaVOICE 100 for his innovative efforts in clinical technology integration and commitment to advancing industry standards.
阅读
Medidata’s vice president of data operations Lori Shields addresses the variance in clinical trial overhead rates across sites in the July issue of The CenterWatch Monthly.
阅读
In a PharmaVOICE interview at the DIA Annual Meeting in Chicago, Medidata president Glen de Vries discusses ways to tackle challenges across the end-to-end clinical development process.
查看
Medidata vice president of partnerships and alliances Graham Bunn discusses the recent acquisition of Clinical Force with Outsourcing-Pharma senior editor Nick Taylor live from the DIA Annual Meeting in Chicago.
查看
Medidata director of product marketing Stan Haavik discusses the importance of process efficiency in clinical trial randomization in the June issue of PharmaVOICE.
阅读
Medidata executive vice president of product and marketing Lineene Krasnow comments on new approaches to address the challenges of growing protocol complexity in the June issue of PharmaVOICE.
阅读
Medidata vice president of product management Rick Piazza discusses the value of integration to maximize the benefits of clinical development technologies in the June issue of PharmaVOICE.
阅读
In the summer issue of European Pharmaceutical Contractor, Medidata senior product marketing manager Joshua Pines discusses how life science organizations can maximize the impact of EDC adoption by revisiting their internal processes and analytics tools.
阅读
Boston University’s Dr. Iain Cockburn discusses the use of Medidata’s trial planning data in a National Bureau of Economic Research study analyzing the increasing costs of clinical trials in this May article from ClinPage.
阅读
Medidata vice president of partnerships and alliances Graham Bunn discusses CRO industry trends, including the importance of strategic relationships with sponsors, in the May issue of Contract Pharma.
阅读
The Cancer Letter interviews Medidata president Glen de Vries about the implementation of Medidata Rave by the National Cancer Institute Cooperative Groups. Published with permission from The Cancer Letter.
阅读
CWWeekly's “Insider Insights” spotlights Medidata in an in-depth interview with Medidata president Glen de Vries.
阅读
Medidata associate product manager Keyur (Kevin) Shroff discusses six steps to streamlining the contracting of sites for clinical studies in the March issue of Journal for Clinical Studies.
阅读
Medidata director of late phase solutions Patrick Chassaigne weighs in on the growing importance of observational research in the March issue of R&D Directions.
阅读
Medidata vice president of regulatory policy Pat Beers Block and senior product director Steve Young provide commentary on the high cost and questionable impact of 100% SDV in the February issue of The CenterWatch Monthly.
阅读
Medidata senior director of product marketing Ron Rubinstein discusses why EDC offers an elegant solution to reducing the burden of SAE reporting for both sites and sponsors in the January/February issue of Bio-IT World.
阅读
2010
Medidata 商务咨询员 Jessica Dolfi 在 Scrip Clinical Research 十二月份的发行刊上探讨在多元复杂的国际环境中如何优化研究机构预算
阅读
Medidata 高级产品总监 Steve Young 和战略动议总监 Ashwin Mundra 在 VIEW on E-Solutions 十一月份/十二月份的发行刊上探讨如何给临床团队装备精良的工具以开展可控风险的研究机构监查
阅读
ClinPage 于 10 月 22 日报道 Medidata 拓展 EDC 功能以及公司如何保持蓬勃的创新朝气
阅读
Medidata 渠道销售副总裁以及 EMEA 销售主管 Steve Heath 在 Journal for Clinical Studies 九月份的发行刊上探讨如何着重开发澳洲这个新兴的全球临床研究市场
阅读
Medidata 高级产品总监 Steve Young 和战略倡议总监 Ashwin Mundra 在 European Pharmaceutical Contractor 九月份的发行刊中讨论可控风险的研究机构监查和部分源文件核查的新范例
阅读
北京大学临床研究所与 Medidata 结盟，共同支持中国新药创新和开发的相关活动
阅读
Medidata 总裁 Glen de Vries 在 DIA 年会的展厅中接受 PharmaVOICE 采访并解释为何“软件即服务型（SaaS）”能改善临床开发过程和优化申办者的研发投资
查看
Medidata 卓越运营副总裁 Douglas Bain 在 9 月 21 日 eCliniqua 发表有关电子原始资料的未来的独到见解
阅读
Medidata 战略倡议总监 Ashwin Mundra 在 Life Science Leader 九月份的发行刊上探讨研究机构监查的最新范例
阅读
Medidata 合作联盟副总裁 Graham Bunn 荣获 PharmaVOICE 100 的提名，作为 CRO 和技术合作伙伴联盟缔结者并领导鼓舞行业发展
阅读
Medidata 运营副总裁 Lori Shields，数据质量与分析经理 Rafael Campo 在 VIEW on Clinical Operations 六月份的发行刊上探讨费用报销和方案复杂性趋势
阅读
Medidata 商务咨询员 Jessica Dolfi，数据质量与分析经理 Rafael Campo 以及其他行业专家，在 Applied Clinical Trials 六月份的发行刊上探讨研究项目经理在全球临床试验运作中如何掌控汇率波动
阅读
FierceBiotech IT 6 月 18 日报道：Medidata Balance 在药物信息协会（DIA）大会首次露面，这是一个全新的随机化和试验供应管理解决方案
阅读
Medidata 总裁 Glen de Vries 于 6 月 16 日在华盛顿特区召开的药物信息协会（DIA）会议上与 Bio-IT World 共同讨论最新发布两个新产品
阅读
Drug Discovery & Development 6 月 16 日报道：Medidata 和 Aris Global 联合宣布 EDC 和药物安全性报告系统实现数据共享
阅读
ClinPage 6 月 15 日报道：Medidata 和 SAS 公司联手提供强大的临床数据报管服务
阅读
Medidata 创始人之一、总裁 Glen de Vries 在 Scrip Clinical Research 六月发行刊中探讨通过预测行业未来十年内的需求运营公司业务，以及公司在前几年世界经济大环境面临最大挑战时成功上市
阅读
Medidata 合作与联盟副总裁 Graham Bunn 在 Contract Pharma 六月发行刊上发表有关 CRO 公司如何摆脱当前行业不景气的局面的独到见解
阅读
Applied Clinical Trials 于 6 月 3 日发行刊上报道 Medidata 迎来了第一个澳大利亚的 CRO 公司加入 ASPire to Win 渠道合作伙伴计划
阅读
Medidata 高级客户关系专员 Sondra Pepe 在 Applied Clinical Trials 6 月 1 日发行刊上发表有关管理全球临床试验的独到见解
阅读
FierceBiotech IT 于 5 月 14 日报道 Medidata 和 Aris Global 携手，成功将用于药物警戒和临床安全性 ARISg 解决方案与用于电子数据采集、管理、报告的 Medidata Rave 进行整合
阅读
Medidata 客户服务负责人 Thomas Ermlich 在 European BioPharmaceutical Review 春季发行刊上阐述公司如何通过流程优化、技术实施和行业信息保障电子临床战略投资最大化
阅读
FierceBiotech IT 在 4 月刊上报道 City of Hope 通过对 10 个电子数据采集解决方案评估后，最后选择 Medidata Rave 作为其内部临床试验的唯一系统
阅读
Medidata 联盟副总裁 Anne Zielinski 在 Life Science Technology 杂志 4 月份发行刊上讨论如何正确选择临床试验技术
阅读
Medidata 信息安全和隐私政策副总裁 Glenn Watt 在 Bio-IT World 1月份发行刊上分享临床开发技术发展中的有关经验
阅读
2009
Medidata 实施服务副总裁 David Gemzik 以及行业其他专家在 Drug Development. 第 4 卷讨论 CDISC 临床研究方案呈现模型，如何通过行业标准优化临床研究
阅读
Roche 在 Data Matters（ACDM通讯刊物）秋季发行刊上阐述公司如何管理成功引进的全新 EDC 系统 Medidata Rave
阅读
Medidata 实施服务副总裁 David Gemzik 在 European Pharmaceutical Contractor 12月份发行刊上阐述了如何借助高质量方案开发过程的帮助, 开展稳健的临床试验
阅读
Medidata 联盟副总裁 Anne Zielinski 在 Contract Pharma 11/12月份发行刊阐述 CRO 和电子数据采集（EDC）之间是天作之合还是冤家对头
阅读
Medidata 实施服务副总裁 David Gemzik 及产品营销高级经理 Sean Cheng 在 VIEW on E-Solutions 11月份发行刊上阐述为什么申办者需要一个整合、闭环的临床过程
阅读
Medidata 副总裁、EMEA 地区主管 Steve Heath 及质量保证高级主管 Tony Hewer 在 Life Science Leader 11月份发行刊上探讨技术如何帮助协调社会、监管和生命科学行业之间的关系
阅读
Medidata 副总裁、EMEA 地区主管 Steve Heath 在 Journal for Clinical Studies 秋季刊中阐述中小型生物技术和制药企业如何能够在当前的经济环境下持续建立电子临床战略
阅读
Medidata 副总裁、EMEA 地区主管 Steve Heath 为Journal for Clinical Studies 7月份发行刊提出建设性的编辑建议
阅读
Medidata Solutions 副总裁 Lori Shields 荣获 PharmaVOICE 100 名最具创新力、创造力和激励型领导力人物。
阅读
Medidata 实施服务副总裁 Mukhtar Ahmed 在 European Pharmaceutical Contractor 探讨亚太地区的业务增长和商业机遇
阅读
Medidata 高级客户关系专员 Sondra Pepe 关于对提议的“阳光法案（Sunshine Act ）”的概览，以及制药企业、生物技术企业和医疗器械公司如何应对联邦政府这些新监管要求所带来的潜在影响。
阅读
Medidata 在 eCliniqua 中阐述电子试验方案解决方案如何帮申办者节省时间和成本。
阅读Medidata 产品营销高级主管 Ron Rubinstein 和 MonitorForHire.com 总裁 Scott Freedman 在 VIEW on Clinical Operations 中阐述 EDC 如何改变临床监查。
阅读
Medidata 总裁 Glen de Vries 和 SAS 健康和生命科学市场部全球主管 Jason Burke 在 Bio-IT World 播客中探讨健康产业的商业创新的当前状况，特别是围绕为临床试验和药物开发提供解决方案。
阅读
Medidata 后期试验解决方案主管 Patrick Chassaigne 和质量保证部副总裁 Fran Nolan 在 Good Practice Clinical Journal 探讨 采用 EDC 开展批准后临床研究如何迎接药政监管的挑战
阅读
阿斯利康对 Medidata Rave 的灵活应用获得 “Bio-IT World 杂志第 5 届最佳实践奖” 的荣誉奖
阅读
Medidata EMEA 主管 Steve Heath 在 R&D Directions 发表关于印度作为临床试验新兴市场的评论
阅读
Medidata 后期解决方案主管 Patrick Chassaigne 在 Journal for Clinical Studies 阐述 EDC 如何帮助和优化上市后研究
阅读
Medidata 全球 CRO 合作副总裁 Graham Bunn 在 PharmaVOICE 阐明全球化的真实含义，并阐述有关药物开发者如何进行全球开发
阅读
Medidata 试验规划解决方案总经理 Ed Seguine 在 International Clinical Trials 阐述现在正是更替方案设计工具的好时机，以及电子方案 （eProtocol） 如何彻底改变传统过程并促进生产效率的提升
阅读
Medidata 支持美国国立标准研究所 （ANSI） 探讨如何在应用电子健康信息支持全球临床研究活动时更加便利
阅读
Medidata 当选为“软件和信息行业协会第 24 届年度 CODiE 奖”最后获胜者，该奖项用于表彰在软件、数字信息、教育技术等行业具有突出业绩和美好前景的企业。Medidata Rave 的 Web 服务 API 功能也跻身 5 名“最佳医学和健康信息产品”亚类的最佳提名名单。
阅读
Medidata 全球 CRO 合作伙伴副总裁 Graham Bunn 在 R&D Directions 中探讨合同研究公司在选择临床试验研究机构所面临的全球机遇
阅读
Medidata 试验规划解决方案运营副总裁 Lori Shields 在 PharmaVOICE 上关于研究者付款的过程优化提出若干专业意见
阅读
Medidata 产品营销高级主管 Ron Rubinstein 在 Bio-IT World 阐述临床系统互操作性降低成本的三个关键因素
阅读
Bio-IT World 阐述 Medidata 如何避免 EDC 培训中的不足
阅读
Medidata EMEA 地区主管 Steve Heath 在 Next Generation Pharmaceuticals 阐述电子数据采集解决方案
阅读
2008
Alan Louie, Health Industry Insights （IDC 公司）研究主管，关于 Medidata 如何为临床研究开发智能方案设计工具提出前瞻性看法。
阅读
药物开发研究 Tufts 中心高级研究人员 Ken Getz 和 Medidata 临床试验规划解决方案总经理 Ed Seguine 在 Bio-IT World 播客上阐述导致临床试验延迟和成本增加等风险的原因，而非在现象描述。
收听
Medidata 开发高级副总裁 Keith Howells 在 IDrugs 探讨在集成 EDC 环境面临的机遇、风险和技术要求
阅读
Medidata 知识管理副总裁 Daniel Mudgett 和知识管理经理 Ashwin Mundra 在 VIEW on E-solutions 讨论如何通过整合的电子教学模块 (eLearning) 使全球临床试验更高效和顺畅。
阅读
Bio-IT World 报导 Medidata 如何通过开发人员交流中心激励创新
阅读
Medidata 全球卓越运营副总裁 Doug Bain 在 Clinical Trials Today 作为最后一部分端到端电子临床互操作性有关 CDASH 问题进行答疑
阅读
Medidata 整合开发副总裁 Andrew Newbigging 在 Applied Clinical Trials 探讨如何实现 ePRO 与 EDC 的完美整合
阅读
Medidata 试验规划解决方案总经理 Ed Seguine，高级数据分析专家 Rafael Campo 和其他行业专家在 American Journal of Therapeutics 评估方案复杂性和方案设计变更对临床试验性能的影响
阅读
Medidata 公司合规主管及全球药政监管事务和质量保证副总裁 Earl Hulihan 在 Applied Clinical Trials 阐述“关于 FDA 在临床研究中使用计算机系统相关指南修改”的前瞻性看法
阅读
ClinPage 与 Medidata 试验规划解决方案总经理 Ed Seguine 一起探讨采用源自实际研究项目数据生成的预算进一步优化方案
阅读
Medidata Solutions 研发主管 Keith Howells 对行业愿景的贡献荣获 PharmaVOICE 赞誉
阅读
Medidata 试验规划解决方案总经理 Ed Seguine 在 View on Clinical Operations 上探讨电子数据采集 (EDC) 与电子化试验方案 (eProtocols) 的效率
阅读
ClinPage 报道 Medidata 收购 Fast Track 后有关方案优化和 EDC 方面等业务
阅读
Medidata 与其他思想领袖企业共同努力，在 Future Pharmaceuticals 播客上分享调整型临床试验阶段性成功经验
收听 | 阅读
PharmaTimes 报道 Medidata 全新的方案开发和规划工具
阅读
Bio-IT World 关于 Medidata 收购“上游”企业 Fast Track 的报道
阅读
ClinPage 报道 Medidata 如何进一步拓展 EDC 业务范围
阅读
Medidata 高层管理人员在 Applied Clinical Trials 杂志阐述了“后期临床研究如何从 EDC 中获益”
阅读
Medidata 高层人员在 Bio-IT World 上发表有关“中国 SFDA 在执行法规更加透明化”的精辟见解
阅读
ClinPage 有关 INC Research 与 Medidata 结盟的报道
阅读
2007
Bio-IT World 报道惠氏 （Wyeth） 选择 Medidata Rave 作为公司 EDC 标准的原因
阅读
Medidata 产品战略副总裁在 the VIEW on E-Solutions 上讨论适应性临床试验和电子临床 (e-clinical) 体系的相互影响
阅读
Medidata 收到 R&D Directions 对 Rave 系统的评论。经R&D Directions 许可后翻印，2007年10月
阅读
Fast Track 临床战略副总裁 Fredric Cohen 在 Next Generation Pharmaceutical讨论了有关定制或购买关键电子临床应用软件应考虑的若干要点
阅读
Fast Track 临床战略副总裁 Fredric Cohen 在 Next Generation Pharmaceutical 阐述了临床方案在药物开发中的地位和重要性
阅读
ClinPage 关于 Medidata 与惠氏 （Wyeth） 企业间交易的报道
阅读
Fast Track 临床战略副总裁 Fredric Cohen 在 Journal of Clinical Research Best Practices 杂志上探讨了智能临床研究方案的有关问题
阅读
Medidata 产品战略副总裁在实用临床试验 Applied Clinical Trials 杂志上介绍 EDC 如何满足上市后研究的需要
阅读
Medidata 全球法规和安全监管副总裁 Bart Cobert, Ph.D.,在 Food and Drug Law Journal （Volume 62, Issue 3） 杂志上发表了他在药物安全性方面的独到见解，并深受 FDLI 的认同。
阅读
Applied Clinical Trials 报道：根据 Fast Track 提供的数据，明确地显示了大部分研究机构要求将启动阶段的费用分开核算，尤其是肿瘤试验
Read
Medidata Solutions 首席执行官和共同创建人 Tarek Sherif 当选为 PharmaVOICE 100 Most Inspiring People in the Life-Sciences Industry （PharmaVOICE 发布的生命科学行业 100 位最具感召力的人士）
阅读
ClinPage.com 的 Mark Uehling 披露了 Medidata 和统计巨头 SAS 如何逐步提高集成程度以及 Medidata Rave 如何向客户提供日臻完善的端到端解决方案
阅读
Medidata 全球监管事务和质量保证副总裁 Earl Hulihan 在 GCP 杂志 Good Clinical Practice Journal 上发表了有关外包的五点经验
阅读
Medidata 首席技术官 Glen de Vries 在 Applied Clinical Trials （实用临床试验） 的增刊中讨论EDC在适应性临床试验中的作用
阅读
Crain's New York Business (瑞恩纽约商业杂志) 将 Medidata 誉为成长最快的本地技术公司之一
阅读
Fast Track 临床运营副总裁 Lori Shields 在 Journal of Clinical Research Best Practices 杂志着重讨论了单例受试者的研究费用和发展趋势
阅读
Medidata 首席技术官 Glen de Vries 在 PharmaVOICE 中讨论EDC并非取代 CDMS，而是其进一步发展和完善
阅读
Fast Track 的首席执行官 Ed Seguine 在 Bioexecutive International阐述目前 EHR 系统和受试者招募方面的不同之处
阅读
2006
Medidata 首席技术官 Glen de Vries 在 Pharmaceutical Executive Europe 中讨论跨越国界管理临床数据和病历档案面临的挑战和机遇
阅读
Medidata 全球监管事务和质量保证副总裁 Earl Hulihan 在 Pharmaceutical Executive 中讨论临床试验中患者的安全和保护
阅读
Fast Track 的首席执行官 Ed Seguine 在 Next Generation Pharmaceutical 上阐述临床开发中的技巧
阅读
Medidata 的共同创办人和首席医药信息官 Ed Ikeguchi 医学博士在 Next Generation Pharmaceutical杂志中讨论“全球性临床试验：挑战或机遇？”
阅读
R&D Directions 发表了 Medidata 首席医药信息官 Ed Ikeguchi 有关“中国为何欢迎EDC”的看法
阅读